VKI has a total leverage of 39% The expense ratio is 3.44% and the non-leverage expense ratio is 0.96%. The fund's 6-month ...

Wall Street’s recent rally has propelled major U.S. stock benchmarks to record territory, with the S&P 500 (SP500) posting a ...

The Spot Solana ETF approval odds are at their peak, at 99% or higher, as the SEC acknowledges another filing. Here’s when it ...

The stock market is back where it started. The S&P 500 was down 0.3% after getting its head above water for a few gasps of air. The Nasdaq Composite was down 0.3%. The Dow was down 180 points, or 0.4% ...

The SEC continues to chug along nicely under the crypto-friendly regime led by new chair Paul Atkins. The agency’s latest ...

The Orange Blossom Classic Committee officially launched the countdown to the 2025 Invesco QQQ Orange Blossom Classic with a ...

Invesco S&P 500® Quality offers better returns than many defensive ETFs with reasonable valuations and a balanced risk ...

The biotechnology industry is split between two very different types of companies. On one side are the large, blue-chip leaders like Amgen Inc. (ticker: AMGN), Gilead Sciences Inc.

Invesco Ltd. significantly ramped up its investment in PayPal Holdings, Inc., increasing its shares by 14.9%. The firm now ...

Invesco also bungled the messaging on its late 2018 purchase of OppenheimerFunds, which should have improved its organic AUM growth, realization rate, and profitability profiles. Instead, the firm's ...

Dallas developer Stonelake Capital Partners remains big player in El Paso industrial market after it sells 7 buildings for ...